News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Taiwan's benchmark climbed 0.45% as Electronic Products Distribution, Machinery and Communication sectors led gains.
  • Australia's ASX 200 fell 0.46% to a one-month low, dragged by Financials, Utilities and Industrials.
  • Abu Dhabi Ports beat Q1 expectations, reporting AED 5.75bn revenue and reaffirming medium-term growth and elevated 2026–27 capex.
  • Vistry cut FY26 adjusted pre-tax profit guidance by up to 20% and paused its share buyback.
  • DEME's Q1 orders doubled to €793m, led by dredging, and management reiterated full-year turnover and EBITDA margin guidance.
  • Spain advanced stricter social media and high-risk AI rules, seeking EU coordination on child safety, privacy and algorithm transparency.
  • A last-day tariff rollback between Washington and Beijing last year rescued a Chinese toy maker, underscoring trade volatility and supply-chain risk.

Latest Articles

Chime records first quarterly profit as consumer spending holds up in Q1

Chime records first quarterly profit as consumer spending holds up in Q1

Chime reported its first-ever quarterly profit in the first quarter, driven by continued consumer spending that bolstered demand for the company's digital banking services. The San Francisco-based fintech posted revenue of $647 million, net income of $53 million and approved a $200 million share buyback. Management cited broad resilience across spe…

Twist Bioscience CAO Executes Automatic Tax-Related Stock Sale

Twist Bioscience CAO Executes Automatic Tax-Related Stock Sale

Robert F. Werner, the Chief Accounting Officer at Twist Bioscience Corp (NASDAQ:TWST), recently executed a transaction involving the sale of common stock. On May 4, 2026, Mr. Werner sold 164 shares at a price per share of $57.1488, resulting in a total transaction value of $9,372. This movement in equity occurs against a backdrop of significant sto…

Piper Sandler Director Executes $7.1 Million Stock Sale

Piper Sandler Director Executes $7.1 Million Stock Sale

Jonathan J. Doyle, a Director and the Head of the Financial Services Group at Piper Sandler Companies (NASDAQ: PIPR), has completed the sale of 90,000 shares of common stock. The transactions, which took place over a two-day period in early May 2026, totaled approximately $7,096,012. This insider activity follows a first quarter for the $5.5 billio…

Coca-Cola Consolidated Reports First Quarter 2026 Results

Coca-Cola Consolidated Reports First Quarter 2026 Results

Coca-Cola Consolidated, Inc. reported a robust first quarter of 2026 with net sales increasing 17% year-over-year, driven by volume growth in both sparkling and still beverage categories. Despite cost pressures from aluminum prices and tariffs, the company achieved a 25% increase in income from operations. The company attributes performance to stro…

Compass Diversified Reports First Quarter 2026 Financial Results

Compass Diversified Reports First Quarter 2026 Financial Results

Compass Diversified Holdings (NYSE: CODI) announced its Q1 2026 results with net revenues of $426.9 million, stable compared to the prior year when adjusting for the deconsolidation of Lugano. The company experienced strong performance in its Branded Consumer segment, with adjusted EBITDA growth of 6.3%. A key highlight was the successful divestitu…

SiTime Reports First Quarter 2026 Financial Results

SiTime Reports First Quarter 2026 Financial Results

SiTime Corporation announced its financial results for the first quarter ended March 31, 2026, reporting revenue of $113.6 million, an 88.3% increase year-over-year. Non-GAAP net income was $38.9 million or $1.44 per diluted share, demonstrating strong operational performance amid continued investment. The company highlighted growth opportunities d…

Arm Raises Outlook as AI-Driven Data Center Demand Boosts Royalties

Arm Raises Outlook as AI-Driven Data Center Demand Boosts Royalties

Arm Holdings said it expects first-quarter revenue above Wall Street estimates, driven by increased uptake of its chip architectures for AI data center workloads. The company cited a rise in royalties connected to data center deployments and reported strong fourth-quarter revenue, while noting memory shortages and supply-chain work to meet new dema…

Strategy Inc Director Executes Stock Option Exercise and Subsequent Sale

Strategy Inc Director Executes Stock Option Exercise and Subsequent Sale

On May 4, 2026, Jarrod M. Patten, a director at Strategy Inc (NASDAQ:MSTR), conducted two significant transactions involving the company's Class A Common Stock. The sequence involved the exercise of stock options followed by an immediate sale of the resulting shares. While the equity markets have seen recent upward movement for the stock, these tra…

Corning Executive John Z. Zhang Executes $2.77 Million Stock Sale

Corning Executive John Z. Zhang Executes $2.77 Million Stock Sale

John Z. Zhang, the Executive Vice President and Chief Commercial and Digital Officer at Corning Inc. (NYSE: GLW), has completed a sale of company common stock totaling approximately $2.77 million. The transaction was disclosed in an SEC Form 4 filing on May 6, 2026. This insider activity follows a period of significant share price appreciation for …

Sanmina Corp Executive Disposes of $225,000 in Common Stock

Sanmina Corp Executive Disposes of $225,000 in Common Stock

Reid Alan McWilliams, the Executive Vice President of Global Human Resources at Sanmina Corporation (NASDAQ: SANM), has completed a sale of common stock. The transaction, which occurred on May 4, 2026, involved the disposal of 1,000 shares at a price of $225.00 per share, totaling an aggregate value of $225,000.Following this specific divestment, M…

argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer

argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer

argenx announced the appointment of Karen Massey as Chief Executive Officer and Tim Van Hauwermeiren as Chairperson of the Board following their Annual General Meeting, signaling a leadership transition as the company moves into its next growth phase. Shareholders approved all agenda items, including remuneration report and reappointments to the Bo…

BridgeBio to Participate in May and June Investor Conferences

BridgeBio to Participate in May and June Investor Conferences

BridgeBio Pharma announces its upcoming participation in major healthcare investor conferences including BofA Securities, Jefferies Global Healthcare, and Goldman Sachs Global Healthcare Conferences. The company will showcase its focus on developing transformative medicines for genetic conditions through fireside chats and live webcasts, aiming to …

Asure Software Sets May & June 2026 Investor Conference Schedule

Asure Software Sets May & June 2026 Investor Conference Schedule

Asure Software, a Nasdaq-listed cloud-based Human Capital Management (HCM) software provider, has announced its participation in several financial conferences including Needham Technology, Media and Consumer Conference, Houlihan Lokey Conference, Craig Hallum Conference, and Northland Capital Markets Growth Conference during May and June 2026. Thes…

Symbotic Reports Second Quarter Fiscal Year 2026 Results

Symbotic Reports Second Quarter Fiscal Year 2026 Results

Symbotic Inc., a leading AI-enabled robotics supply chain company, reported robust financial results for Q2 fiscal 2026 ending March 28, 2026, with revenue of $676 million (23% YoY growth), a net income of $9 million compared to a $10 million loss in the prior year, and adjusted EBITDA doubling to $78 million. The company increased its deployed sys…

New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years

New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years

Ascendis Pharma reported positive two-year data from their pivotal ApproaCH trial showing that children aged 5 and older with achondroplasia treated with once-weekly TransCon CNP (navepegritide) exhibited significantly greater growth velocity compared to placebo. The treatment demonstrated sustained growth benefits with a favorable safety profile, …